Iridocorneal melanoma associated with type 1 neurofibromatosis: A clinicopathologic study

Ophthalmology

Volumn 106, Issue 3, 1999, Pages 614-618

  Rehany, Uri ^a   Rumelt, Shimon ^a  

^a WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

ADULT; ANTERIOR EYE CHAMBER; ARTICLE; CARCINOMA IN SITU; CASE REPORT; CORNEA TUMOR; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; IRIS TUMOR; NEURAL CREST; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SCHWANN CELL;

EID: 0033497419     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90125-2     Document Type: Article

References (18)

1. Riccardi VM. Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 1982;7:1-34.
2. Kramer W. Lesions of the central nervous system in multiple neurofibromatosis. Psychiatr Neurol Neurochir 1971;74:349-68.
3. Ragge NK. Clinical and genetic patterns of neurofibromatosis 1 and 2. Br J Ophthalmol 1993;77:662-72.
4. Mastrangelo MJ, Goepp CE, Patel YA, Clark WH Jr. Cutaneous melanoma in a patient with neurofibromatosis. Arch Dermatol 1979;115:854-5.
5. Brasfield RD, Das Gupta TK. Von Recklinghausen's disease: a clinicopathological study. Ann Surg 1972;175:86-104.
6. Antle CM, Damji KF, White VA, Rootman J. Uveal malignant melanoma and optic nerve glioma in von Recklinghausen's neurofibromatosis. Br J Ophthalmol 1990;74:502-4.
7. Kersten RC, Tse DT, Anderson R. Iris melanoma. Nevus or malignancy? Surv Ophthalmol 1985;29:223-33.
8. Donders PC. Ring melanoma of the iris. Iridocorneal endothelial syndrome. Int Ophthalmol 1985;7:161-7.
9. Reese AB. Tumors of the eye, 3rd ed. Hagerstown: Harper & Row, 1976;189,193.
10. Margo CE, Groden LR. Iris melanoma with extensive corneal invasion and metastases. Am J Ophthalmol 1987;104:543-4.
11. Bolande RP. The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol 1979;5:409-29.
12. Bahn CF, Falls HF, Varley GA, et al. Classification of corneal endothelial disorders based on neural crest origin. Ophthalmology 1984;91:558-63.
13. Ross AH, Pleasure D, Sonnenfeld K, et al. Expression of melanoma-associated antigens by normal and neurofibroma Schwann cells. Cancer Res 1986;46:5887-92.
14. Nichols DH, Weston JA. Melanogenesis in cultures of peripheral nervous tissue. I. The origin and prospective fate of cells giving rise to melanocytes. Dev Biol 1997;60:217-25.
15. Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat Genet 1993;3:122-6.
16. Nakamura T. Genetic markers and animal models of neurocristopathy. Histol Histopathol 1995;10:747-59.
17. Suzuki H, Takahashi K, Yasumoto K, Shibahara S. Activation of the tyrosinase gene promoter by neurofibromin. Biochem Biophys Res Commun 1994;205:1984-91.
18. Johnson MR, DeClue JE, Felzmann S, et al. Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 1994; 14:641-5.